abstract |
A formulation of conjugates of tubulysin analogs with a cell-binding molecule having a structure represented by Formula (I), wherein T, L, m, n, ----, R 1 , R 2 , R 3 , R 4 , R 1 , R 6 , R 7 , R 1 , R 9 , R 10 , R 11 , R 12 , and R 13 are as defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease. |